Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Previously submitted to: JMIR Public Health and Surveillance (no longer under consideration since Apr 16, 2024)

Date Submitted: Mar 14, 2023
Open Peer Review Period: Mar 13, 2023 - Mar 27, 2023
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Global, regional, and national temporal trends in mortality and disability-adjusted life years for cardiovascular disease attributable to low temperature during 1990–2019: an age-period-cohort analysis of the global burden of disease 2019 study

  • Xiaofei Li; 
  • Zeye Liu; 
  • Jing Xie; 
  • Hua Shao; 
  • Liqun Ren; 
  • Shenqi Jing; 
  • Tao Shan; 
  • shan Lu; 
  • Ruibing Xia; 
  • Ruibing Xia; 
  • Xin Zhang; 
  • Naifeng Liu; 
  • Yun Liu; 
  • Naifeng Liu

ABSTRACT

Background:

Cardiovascular disease (CVD) is the most common non-communicable disease (NCD) burden attributable to low temperature. Few studies have focused on the worldwide region-specific relationship between CVDs and low temperature.

Objective:

We aimed to depict an overview of trends in mortality and disability-adjusted life years (DALYs) for CVDs and its subtypes attributable to low temperature over the past 30 years in 204 countries and regions, along with the associations of these trends with age, period, and birth cohorts.

Methods:

Data on the estimated burden of CVDs (including ischemic heart disease, hypertensive heart disease, and stroke) attributable to low temperature were obtained from the Global Burden of Disease Study 2019. We utilized an age-period-cohort model to estimate overall annual percentage changes in mortality (net drifts), annual percentage changes from 15~19 to 81~85 years (local drifts), period and cohort relative risk (period/cohort effects) between 1990 and 2019.

Results:

Among NCDs, CVDs had the highest mortality rate and DALY loss attributable to low temperature worldwide in 2019. China, Russia, India, the United States, and Ukraine reported the top five high numbers of death, accounting for 59.1% of global deaths in 2019. Although the number of CVDs death due to low temperature has increased by 35.9% (from 812 to 1104 million), an overall decreasing trend in mortality (net drift, -2.19%,95% CI [-2.34%,-2.05%] per year) and DALYs (net drift, -2.17%,95% CI[-2.26%,-2.09%] per year) loss was found. Countries or regions with high socio-demographic index (SDI) tend to have both high CVD mortality in 2019 (19.45%, 95% CI [14.54%,24.17%]) and mortality decline rate (from 1990 to 2019, net drift, -3.25% [-3.76%,-2.73%] per year), and deaths were concentrated in people over 80 years old (62.6%). The opposite outcome was found in those countries or regions with low SDI (mortality in 2019, 3.74%, 95%CI [2.46%,4.92%], net drift, -1.13% [-1.21%, -1.04%]). Similar trends were found in age-standardized rates and net drift for DALYs. Men have a higher disease burden and die at a younger age globally compared to women.

Conclusions:

Mortality and DALY loss from CVD attributable to low temperature showed an overall decreasing trend globally, and SDI levels, sex, age, and geographic location contributed to the diversity of the disease burden worldwide. Countries and regions need to adopt individualized responses to tackle diseases.


 Citation

Please cite as:

Li X, Liu Z, Xie J, Shao H, Ren L, Jing S, Shan T, Lu s, Xia R, Xia R, Zhang X, Liu N, Liu Y, Liu N

Global, regional, and national temporal trends in mortality and disability-adjusted life years for cardiovascular disease attributable to low temperature during 1990–2019: an age-period-cohort analysis of the global burden of disease 2019 study

JMIR Preprints. 14/03/2023:47231

DOI: 10.2196/preprints.47231

URL: https://preprints.jmir.org/preprint/47231

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.